2015 Michigan Proposal 1

Fresh Tracks Therapeutics Announces Adjournment of Special Meeting of Stockholders

Retrieved on:

Friday, November 17, 2023

Sale, Liquidation, Therapy, Annual report, ANY, 2015 Michigan Proposal 1, Proxy, Special, Person, File, Track, Certificate, Name, Security (finance), Auction, Dissolution, Fresh

BOULDER, Colo., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Fresh Tracks Therapeutics, Inc. (Nasdaq: FRTX) (“Fresh Tracks” or the “Company”) announced today that its special meeting of stockholders (the “Special Meeting”) has been adjourned to Thursday, November 30, 2023 at 10 a.m. Mountain Time with respect to both proposals described in Fresh Tracks’ definitive proxy statement filed with the U.S. Securities and Exchange Commission (the “SEC”) on October 20, 2023 (the “Proxy Statement”).

Key Points:

In addition, the record date for determining stockholders entitled to vote at the Special Meeting will remain the close of business on October 17, 2023.
During the current adjournment, Fresh Tracks continues to solicit votes from its stockholders with respect to both proposals set forth in the Proxy Statement.
Proxies previously submitted with respect to the Special Meeting will be voted on both proposals at the reconvened Special Meeting as indicated therein, unless properly revoked, and stockholders who have previously submitted a proxy need not take any action.
If Fresh Tracks’ stockholders do not approve Proposal 1, Fresh Tracks intends to seek judicial dissolution, which is likely to be costly and time-consuming and would reduce the amount of cash distributable to Fresh Tracks’ stockholders associated with the Company’s dissolution.

Vyant Bio Announces 77,522 Votes Needed to Approve Sale of Assets 175,721 Votes Needed to Approve Winddown of Business Adjournment of Special Meeting of Stockholders

Retrieved on:

Wednesday, October 11, 2023

Proxy statement, OTC, Proxy card, Proiphys, Special, Proxy, Dissolution, Cyprus Securities and Exchange Commission, Asset purchase agreement, 2015 Michigan Proposal 1, Proposal 2, Security (finance), Sale, Holding company

The adjourned Special Meeting will reconvene on October 19, 2023 at 11:00 a.m. Eastern Time at https://www.viewproxy.com/vynt/2023 .

Key Points:

The adjourned Special Meeting will reconvene on October 19, 2023 at 11:00 a.m. Eastern Time at https://www.viewproxy.com/vynt/2023 .
The record date of August 4, 2023 for the adjourned Special Meeting remains the same.
Stockholders of record may attend the virtual webcast meeting by logging in through the same method.
Stockholders who have already voted their shares on the proposals contained in the Proxy Statement do not need to vote again.

Vyant Bio Announces Adjournment of Special Meeting of Stockholders

Retrieved on:

Thursday, September 28, 2023

Dissolution, Proxy statement, Shareholder, Proxy card, 2015 Michigan Proposal 1, Special, Proxy, Proiphys, Asset purchase agreement, Sale, OTC, Security (finance), Holding company

The adjourned Special Meeting will reconvene on October 11, 2023 at 11:00 a.m. Eastern Time at https://www.viewproxy.com/vynt/2023 .

Key Points:

The adjourned Special Meeting will reconvene on October 11, 2023 at 11:00 a.m. Eastern Time at https://www.viewproxy.com/vynt/2023 .
The record date of August 4, 2023 for the adjourned Special Meeting remains the same.
Proxies previously submitted will be voted at the adjourned Special Meeting, and stockholders who have previously submitted a proxy or otherwise voted need not take any action.
Vyant Bio encourages all stockholders, as of the record date on August 4, 2023, who have not yet voted to do so promptly.

Vyant Bio Announces Adjournment of Special Meeting of Stockholders

Retrieved on:

Wednesday, September 20, 2023

Dissolution, Proxy statement, Proxy card, 2015 Michigan Proposal 1, Proxy, Proiphys, Asset purchase agreement, Sale, OTC, Special, Security (finance), Holding company

The adjourned Special Meeting will reconvene on September 28, 2023 at 11:00 a.m. Eastern Time at https://www.viewproxy.com/vynt/2023 .

Key Points:

The adjourned Special Meeting will reconvene on September 28, 2023 at 11:00 a.m. Eastern Time at https://www.viewproxy.com/vynt/2023 .
The record date of August 4, 2023 for the adjourned Special Meeting remains the same.
Proxies previously submitted will be voted at the adjourned Special Meeting, and stockholders who have previously submitted a proxy or otherwise voted need not take any action.
Vyant Bio encourages all stockholders, as of the record date on August 4, 2023, who have not yet voted to do so promptly.

Stratasys Announces Extraordinary General Meeting of Shareholders

Retrieved on:

Wednesday, August 23, 2023

Stratasys Ltd. (Nasdaq: SSYS) (“Stratasys” or the “Company”) today announced that it will hold an Extraordinary General Meeting of Shareholders (the “Meeting”) on Thursday, September 28, 2023, at 3:00 p.m. Israel time/ 8:00 a.m. Eastern time, at Meitar Law Offices, 16 Abba Hillel Road, 10th floor, Ramat Gan 5250608, Israel.

Key Points:

Stratasys Ltd. (Nasdaq: SSYS) (“Stratasys” or the “Company”) today announced that it will hold an Extraordinary General Meeting of Shareholders (the “Meeting”) on Thursday, September 28, 2023, at 3:00 p.m. Israel time/ 8:00 a.m. Eastern time, at Meitar Law Offices, 16 Abba Hillel Road, 10th floor, Ramat Gan 5250608, Israel.
Stratasys’ Board unanimously recommends that Stratasys’ shareholders vote “FOR” each of Proposals 1, 2 and 3.
The shareholders will furthermore transact such other business as may properly come before the Meeting or any adjournment thereof.
It will also provide additional logistical information related to the Meeting, the procedure for Stratasys shareholders to vote by proxy or voting instruction form, and various other information related to the Meeting.

EQS-News: Iute Group EUR 2021/2026 bondholders with great consent to amend terms and conditions – Bondholders’ Meeting secures greater financial flexibility for growth

Retrieved on:

Friday, August 4, 2023

Financial adviser, 2022 Michigan Proposal 3, Proposal 2, 2015 Michigan Proposal 1, Trust, Documentation, Acquisition, ISIN, Growth, Security (finance), IUT

Iute Group, a leading European personal finance group, through its fully owned subsidiary IuteCredit Finance S.à r.l., has received great consent from bondholders to amend the terms and conditions of its EUR 2021/2026 bonds (ISIN: XS2378483494).

Key Points:

Iute Group, a leading European personal finance group, through its fully owned subsidiary IuteCredit Finance S.à r.l., has received great consent from bondholders to amend the terms and conditions of its EUR 2021/2026 bonds (ISIN: XS2378483494).
The participants voted with 95% almost unanimously in favor of each of the resolutions, thereby also duly meeting the majority thresholds.
Tarmo Sild, Group CEO: “We thank the bondholders for their trust in Iute.
Iute grows and develops thanks to joint efforts, in which the people who invest their money in Iute play a major role.

Lifeway Foods® Announces Annual Meeting Results and Provides Update to Shareholders

Retrieved on:

Friday, June 16, 2023

MORTON GROVE, Ill., June 16, 2023 /PRNewswire/ -- The Board of Directors (the "Board") of Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced the results of its 2023 Annual Meeting of Shareholders (the "Annual Meeting") and provided other updates to shareholders.

Key Points:

At the Annual Meeting held on June 15, 2023, shareholders supported Proposal 1, electing the Company's eight nominees to the Board.
Notably, a leading independent shareholder advisory firm, Institutional Shareholder Services Inc., recommended that shareholders vote for the Company's eight director nominees.
In connection with this engagement, the independent members of the Board stated:
"We are always open to considering all available avenues to maximize shareholder value.
Chief Executive Officer Julie Smolyansky and the entire leadership team are successfully executing our Lifeway 2.0 strategy to optimize growth, productivity and profitability.

Servotronics Announces 2023 Annual Shareholder Meeting Results

Retrieved on:

Wednesday, June 14, 2023

NYSE American, SVT, Growth, Report, 2018 Michigan Proposal 3, NYSE, Proposal 2, 2015 Michigan Proposal 1, Holding company, Servotron

ELMA, N.Y., June 14, 2023 /PRNewswire/ -- Servotronics, Inc. (NYSE American – SVT) a designer and manufacturer of servo-control components and other advanced technology products today announced the results of voting at the Company's 2023 Annual Shareholder meeting.

Key Points:

ELMA, N.Y., June 14, 2023 /PRNewswire/ -- Servotronics, Inc. (NYSE American – SVT) a designer and manufacturer of servo-control components and other advanced technology products today announced the results of voting at the Company's 2023 Annual Shareholder meeting.
"We would like to thank all Servotronics shareholders for their continued support and participation in our Annual Shareholder meeting this year," stated William F. Farrell, Chief Executive Officer of the Company.
"The results of this meeting have demonstrated that shareholders believe in our long-term strategy which will generate sustainable growth and maximize shareholder value.
The final results of the meeting have been reported on a Current Report filed by Servotronics on Form 8-K with the U.S. Securities and Exchange Commission.

Concerned Shareholders of Cano Health Reiterate the Need for Changes in Leadership and Strategy at the Company Following Massive Value Destruction

Retrieved on:

Wednesday, June 14, 2023

Consulting, Professional Services, Finance, GREEN, 2015 Michigan Proposal 1, Disclosure, Annual Meetings of the International Monetary Fund and the World Bank Group, Delaware Court, Annual general meeting, CANO, Court, Delaware Court of Chancery, NYSE, Shareholder

It is critically important that this shared desire for urgent change translates to resounding WITHHOLD votes for the two directors standing for election at tomorrow’s Annual Meeting.

Key Points:

It is critically important that this shared desire for urgent change translates to resounding WITHHOLD votes for the two directors standing for election at tomorrow’s Annual Meeting.
We, as stockholders, cannot afford to continue to rely on the same leadership that has presided over abysmal capital allocation, dismal corporate governance and disclosure practices, and disastrous strategic decisions.
The stakes are far too high now that Cano has burned through more than a billion dollars in cash and seen its stock price plunge approximately 90%.
We sincerely hope that the Board and leadership take to heart our desire – shared by many stockholders – for increased integrity and accountability.

ISS and Glass Lewis Recommend Cano Health Stockholders WITHHOLD on Incumbent Directors Dr. Alan Muney and Kim Rivera

Retrieved on:

Wednesday, June 7, 2023

“We appreciate that ISS and Glass Lewis have validated our campaign for boardroom change by recommending stockholders withhold their support for Dr. Muney and Ms. Rivera at the upcoming Annual Meeting.

Key Points:

“We appreciate that ISS and Glass Lewis have validated our campaign for boardroom change by recommending stockholders withhold their support for Dr. Muney and Ms. Rivera at the upcoming Annual Meeting.
We believe that Dr. Muney and Ms. Rivera bear direct responsibility for many recent anti-stockholder actions given their roles leading key committees.
The effort to create the special committee was spearheaded by Muney and Rivera.
We urge stockholders to vote WITHHOLD on Proposal 1, the election of Dr. Muney and Ms. Rivera, on any proxy card received (the GREEN or WHITE proxy card).